Last reviewed · How we verify

NCT06198374: Pro-Health

Impact of Propionic Acid on Regulatory T Cell Function in Healthy Adults ( Pro-Health)

Active, enrolled NA Last updated 17 February 2025
What this trial tests

NA trial testing Sodium propionate in Healthy in 24 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
8 January 2024
Primary endpoint
28 February 2024
30 May 2025

Quick facts

Lead sponsorCharite University, Berlin, Germany
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposebasic science
Enrollment24
Start date8 January 2024
Primary completion28 February 2024
Estimated completion30 May 2025
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Charite University, Berlin, Germany

Who can join

Adults 18 to 40, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pro-Health is a single-center, double-blind, randomized and placebo-controlled intervention study in healthy adults. The investigators address the effect of a dietary food supplementation of propionic acid on the immune system and the function of the intestinal barrier in healhty adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Sodium propionate

Trials testing the same drug.

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Charite University, Berlin, Germany trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06198374.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing